About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mer-TK in Human Cardiac Cells

NCT04322630·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ann & Robert H Lurie Children's Hospital of Chicago

Age

0–19

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

All patient ages from birth-19 years-old as well as cyanotic and acyanotic cardiac lesions will be included

You may not be if

Patients will be excluded if both pre and post bypass blood samples are not available.

The record

StatusCompleted

PhaseNo phase

Taking part50

StartedMay 2019

UpdatedAug 12, 2021

Conditions

Myocardial Inflammation Myocardial Infarction

Where1

Ann & Robert H Lurie Children's Hopsital
Chicago, Illinois, United States

Clareo Health | Mer-TK in Human Cardiac Cells